Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 28, 2011Journal of Antimicrobial Chemotherapy

Does broad-spectrum  -lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria?

View Full Paper
Ask AI
Bookmark
Share

Authors

PNPatrice NordmannUniversité Paris-SudLPLaurent PoirelUniversité Paris-SudMTMark A. TolemanCardiff University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Nordmann et al. (2011) studied this question.

synapsesocial.com/papers/6a705cf2f44fa9f079ddfc0chttps://doi.org/10.1093/jac/dkq520
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Identification of NDM-1-producing Enterobacteriaceae in Norway2010 · 82 citations
  2. 2Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India2010 · 247 citations
  3. 3Characterization of a New Metallo-β-Lactamase Gene, <i>bla</i> <sub>NDM-1</sub> , and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in <i>Klebsiella pneumoniae</i> Sequence Type 14 from India2009 · 2,546 citations
  4. 4Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-32002 · 287 citations
  5. 5Emergence of High Levels of Extended-Spectrum-β-Lactamase-Producing Gram-Negative Bacilli in the Asia-Pacific Region: Data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program, 20072009 · 226 citations